EUVIMEDEUVIMED entdecken
Crossref

Methylglyoxal‐derived hydroimidazolone ( MG ‐ H1 ) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes

Sonoko Kitao iD, Tsuyoshi Okura iD, Yuichi Ito, Satomi Endo, Yoshinori Ichihara, Tatsuya Sawano, Risa Nakamura, Kazuhiko Matsuzawa, Yuri Nomi, Etsuko Ueta, Yuzuru Otsuka, Keiko Nagata und 4 weitere

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Sonoko Kitao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Multidisciplinary Internal Medicine, Department of Endocrinology and Metabolism, School of Medicine, Faculty of Medicine, Tottori Univers…. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, Imidazoles, Mechanistic Target of Rapamycin Complex 2. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Methylglyoxal‐derived hydroimidazolone (MG‐H1), one of the advanced glycation end‐products (AGEs), has been a potential biomarker of type 2 diabetes (T2DM), which is strongly related to insulin resistance. However, the relationship between the dynamics of MG‐H1 and insulin resistance has not been characterized, and its mechanism on insulin resistance is unknown. In this study, we aimed to investigate the relationship between MG‐H1 and insulin resistance in the clinical study of Japanese individuals and identify the molecular mechanisms underlying MG‐H1 associated phenomena in vitro.

Methods

We performed the meal tolerance test (MTT) and hyper‐insulinemic–euglycemic clamp analysis in 19 patients with T2DM and 19 participants without diabetes (non‐DM). We measured their fasting and postprandial MG‐H1 using liquid chromatography–tandem mass spectrometry (LC–MS/MS). In addition, we evaluated the effects of MG‐H1 on glucose uptake and insulin signalling in C2C12 skeletal myocytes.

Results

The postprandial MG‐H1 and the area under the curve (AUC) of MG‐H1 in MTTs were significantly negatively correlated with the glucose disposal rate (GDR) in clamp studies both in the T2DM ( r = −0.72 [ p < 0.001]) and non‐DM ( r = −0.54 [ p < 0.05]) groups. In cultured C2C12 skeletal myocytes, pre‐treatment with MG‐H1 inhibited insulin‐stimulated phosphorylation of Akt and glucose uptake, via the activation of mechanistic target of rapamycin complex 2 (mTORC2).

Conclusions

In clinical study findings revealed that postprandial MG‐H1 was a novel marker of insulin resistance in Japanese individuals, and in vitro findings using cultured C2C12 skeletal myocytes suggested that MG‐H1 disturbs insulin signalling via the mechanisms of mTORC2 activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceDiabetes Mellitus, Type 2ImidazolesMechanistic Target of Rapamycin Complex 2InsulinPyruvaldehydeMuscle Fibers, SkeletalHumansMaleMiddle AgedFemaleSignal TransductionBiomarkersGlucose Clamp TechniqueJapanAgedPostprandial PeriodGlycation End Products, AdvancedAnimalsMiceCells, CulturedEast Asian PeopleOrnithine

Stichwörter der Autor:innen

Aktadvanced glycation end‐products (AGEs)glucose uptakehyper‐insulinemic–euglycemic clampinsulin resistancemethylglyoxal‐derived hydroimidazolone (MG‐H1)

Substanzen

BiomarkersImidazolesMechanistic Target of Rapamycin Complex 2InsulinPyruvaldehydeNdelta-(5-hydro-5-methyl-4-imidazolon-2-yl)ornithineGlycation End Products, AdvancedOrnithine

Autor:innen und Institutionen

  • Division of Multidisciplinary Internal Medicine, Department of Endocrinology and Metabolism, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.
  • Division of Pharmacology, Department of Pathophysiological and Therapeutic Sciences, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.
  • Faculty of Applied Life Sciences, Niigata University of Pharmacy and Medical and Life Sciences, Niigata, Japan.
  • School of Health Science, Tottori University Faculty of Medicine, Yonago, Japan.
  • Ochanomizu University, Tokyo, Japan.
  • Department of Community-based Family Medicine, Tottori University Faculty of Medicine, Yonago, Japan.

ORCID-Profile: Sonoko Kitao, Tsuyoshi Okura

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kitao, S., Okura, T., Ito, Y., Endo, S., Ichihara, Y., Sawano, T., Nakamura, R., Matsuzawa, K., Nomi, Y., Ueta, E., Otsuka, Y., Nagata, K., Miake, J., Taniguchi, S. I., Yamamoto, K., & Imamura, T. (2026). Methylglyoxal‐derived hydroimidazolone ( MG ‐ H1 ) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70489

Vancouver

Kitao S, Okura T, Ito Y, Endo S, Ichihara Y, Sawano T, et al. Methylglyoxal‐derived hydroimidazolone ( MG ‐ H1 ) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70489

BibTeX
@article{Kitao2026,
  author = {Kitao, Sonoko and Okura, Tsuyoshi and Ito, Yuichi and Endo, Satomi and Ichihara, Yoshinori and Sawano, Tatsuya and Nakamura, Risa and Matsuzawa, Kazuhiko and Nomi, Yuri and Ueta, Etsuko and Otsuka, Yuzuru and Nagata, Keiko and Miake, Junichiro and Taniguchi, Shin-Ichi and Yamamoto, Kazuhiro and Imamura, Takeshi},
  title = {Methylglyoxal‐derived hydroimidazolone ( MG ‐ H1 ) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70489}
}
Kostenlos starten →